MTOR and lung carcinoma: Interestingly, we found that ARHGs with active copy number increase (e.g. MYC, EIF4EBP1, EGFR) and ARHGs with active copy number loss (e.g. ATG16L1, MTOR, ULK1) also showed high expression in lung cancer tissues (Fig 1C).